Gilead Sciences Inc. said it will charge the U.S. government and other developed countries US$390 ($543.36) per vial for its coronavirus-fighting drug remdesivir, or about US$2,340 for a typical five-day course of treatment.
(June 30): The World Health Organization warned the worst of the coronavirus pandemic is still to come because of a lack of global solidarity. More U.S. areas took steps to scale back reopenings, with Arizona closing bars and New Jersey halting plans for indoor dining.
Daily deaths in Iran reached a record, while cases in Austria rose to the highest level since mid-May.
